The exposome and health: Where chemistry meets biology
暂无分享,去创建一个
[1] T. Pawson,et al. Network medicine , 2008, FEBS letters.
[2] Alessandro Vespignani,et al. Dynamical Processes on Complex Networks , 2008 .
[3] Emma L. Schymanski,et al. MetFrag relaunched: incorporating strategies beyond in silico fragmentation , 2016, Journal of Cheminformatics.
[4] Ashutosh Kumar Singh,et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.
[5] A. Barabasi,et al. Predicting perturbation patterns from the topology of biological networks , 2018, Proceedings of the National Academy of Sciences.
[6] Dean P. Jones,et al. The Exposome: Molecules to Populations. , 2019, Annual review of pharmacology and toxicology.
[7] John P A Ioannidis,et al. Researching Genetic Versus Nongenetic Determinants of Disease: A Comparison and Proposed Unification , 2009, Science Translational Medicine.
[8] Atul J. Butte,et al. An Environment-Wide Association Study (EWAS) on Type 2 Diabetes Mellitus , 2010, PloS one.
[9] David Balshaw,et al. Assessing the Exposome with External Measures: Commentary on the State of the Science and Research Recommendations , 2017, Annual review of public health.
[10] Xavier Domingo-Almenara,et al. Exposome-Scale Investigations Guided by Global Metabolomics, Pathway Analysis, and Cognitive Computing. , 2017, Analytical chemistry.
[11] A. Brookes,et al. GWAS Central: a comprehensive resource for the comparison and interrogation of genome-wide association studies , 2013, European Journal of Human Genetics.
[12] Andrew R. Leach,et al. ChEMBL: towards direct deposition of bioassay data , 2018, Nucleic Acids Res..
[13] Benno Schwikowski,et al. From the exposome to mechanistic understanding of chemical-induced adverse effects. , 2017, Environment international.
[14] N. Mostafavi,et al. Perturbation of metabolic pathways mediates the association of air pollutants with asthma and cardiovascular diseases. , 2018, Environment international.
[15] David S. Wishart,et al. BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification , 2019, Journal of Cheminformatics.
[16] David S. Wishart,et al. HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..
[17] Shuzhao Li,et al. Understanding mixed environmental exposures using metabolomics via a hierarchical community network model in a cohort of California women in 1960's. , 2020, Reproductive toxicology.
[18] Jian Ji,et al. Software Tools and Approaches for Compound Identification of LC-MS/MS Data in Metabolomics , 2018, Metabolites.
[19] Evan Bolton,et al. PubChem 2019 update: improved access to chemical data , 2018, Nucleic Acids Res..
[20] Emma L. Schymanski,et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. , 2014, Environmental science & technology.
[21] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[22] Nuno Bandeira,et al. Untargeted mass spectrometry-based metabolomics approach unveils molecular changes in raw and processed foods and beverages. , 2020, Food chemistry.
[23] Ginestra Bianconi,et al. Multilayer Networks , 2018, Oxford Scholarship Online.
[24] Antony J. Williams,et al. The CompTox Chemistry Dashboard: a community data resource for environmental chemistry , 2017, Journal of Cheminformatics.
[25] Ginestra Bianconi,et al. Multilayer Networks , 2018, Oxford Scholarship Online.
[26] Nilanjan Chatterjee,et al. Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits , 2018, Nature Genetics.
[27] Paolo Vineis,et al. Deciphering the complex: Methodological overview of statistical models to derive OMICS‐based biomarkers , 2013, Environmental and molecular mutagenesis.
[28] Petter Holme,et al. Temporal Networks as a Modeling Framework , 2021, 2103.13586.
[29] U. Sauer,et al. Biological insights through nontargeted metabolomics. , 2015, Current opinion in biotechnology.
[30] L. S. Haug,et al. Early-life exposome and lung function in children in Europe: an analysis of data from the longitudinal, population-based HELIX cohort. , 2019, The Lancet. Planetary health.
[31] Jaroslav Slobodnik,et al. Emerging pollutants in the EU: 10 years of NORMAN in support of environmental policies and regulations , 2018, Environmental Sciences Europe.
[32] Stephen M Rappaport,et al. Environment and Disease Risks , 2010, Science.
[33] A. Haines,et al. The Lancet Commission on pollution and health , 2017, The Lancet.
[34] Oliver Fiehn,et al. Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach , 2019, Environmental health perspectives.
[35] C. Austin,et al. Improving the Human Hazard Characterization of Chemicals: A Tox21 Update , 2013, Environmental health perspectives.
[36] Emma L. Schymanski,et al. Strategies to characterize polar organic contamination in wastewater: exploring the capability of high resolution mass spectrometry. , 2014, Environmental science & technology.
[37] A. Tamakoshi,et al. The Relationship between Green Tea and Total Caffeine Intake and Risk for Self-Reported Type 2 Diabetes among Japanese Adults , 2006, Annals of Internal Medicine.
[38] C. Wild. Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology , 2005, Cancer Epidemiology Biomarkers & Prevention.
[39] Emma L. Schymanski,et al. Connecting environmental exposure and neurodegeneration using cheminformatics and high resolution mass spectrometry: potential and challenges. , 2019, Environmental science. Processes & impacts.
[40] Karan Uppal,et al. High-resolution metabolomics of occupational exposure to trichloroethylene , 2016, International journal of epidemiology.